Controlling the bioactivity of a peptide hormone in vivo by reversible self-assembly
The clinical potential of peptide therapeutic agents can only be fully realised once their physicochemical and pharmacokinetic properties are precisely controlled. Here the authors show a reversible peptide self-assembly strategy to control and prolong the bioactivity of a native peptide hormone in...
Guardado en:
Autores principales: | Myriam M. Ouberai, Ana L. Gomes Dos Santos, Sonja Kinna, Shimona Madalli, David C. Hornigold, David Baker, Jacqueline Naylor, Laura Sheldrake, Dominic J. Corkill, John Hood, Paolo Vicini, Shahid Uddin, Steven Bishop, Paul G. Varley, Mark E. Welland |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c7f770bfea9c44cf8e0311310d874e5d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biocompatibility pathways and mechanisms for bioactive materials: The bioactivity zone
por: David F. Williams
Publicado: (2022) -
Plant-Based Colloidal Delivery Systems for Bioactives
por: Yunbing Tan, et al.
Publicado: (2021) -
Fruit Derived Potentially Bioactive Bioengineered Silver Nanoparticles
por: Baker A, et al.
Publicado: (2021) -
A universal reporter cell line for bioactivity evaluation of engineered cytokine products
por: Jacqueline Mock, et al.
Publicado: (2020) -
The bone hormones and their potential effects on glucose and energy metabolism
por: Addai Daniel, et al.
Publicado: (2019)